Anirvin Bommaraju
Anirvin Bommaraju has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
Aaron Gette
QOL San Jose California USA
1 shared publicationAlex Wright
QOL San Jose California USA
1 shared publicationBlake Morrison
QOL San Jose California USA
1 shared publicationFrank Pezzullo
QOL San Jose California USA
1 shared publication- James R. Berenson
Institute for Myeloma & Bone Cancer Research, West Hollywood, CA
1 shared publication - Jamie Cheung
Berenson Cancer Center West Hollywood California USA
1 shared publication
Latest Publications
- Open Access
- 16 November 2026
- Published by Wiley in British Journal of Haematology
A real‐time text‐based assessment tool for monitoring symptoms and quality of life for multiple myeloma patients: A feasibility study
Summary: Patient‐reported outcome (PRO) and quality of life (QoL) assessments for multiple myeloma (MM) patients are traditionally collected at infrequent intervals using burdensome instruments, resulting in limited clinical visibility between visits. This creates a critical gap in care, as evolving symptoms and treatment‐related toxicities frequently occur outside scheduled encounters and may remain unrecognized. A single‐centre pilot study evaluated the feasibility and clinical utility of a short message service (SMS)‐based remote monitoring platform, assessing 8 symptoms and 10 QoL domains for 58 MM patients over 90 days. End‐points included feasibility and engagement measured using completion rates, time burden and identification of clinically actionable events. A total of 1604 assessments were delivered, with an overall completion rate of 85.5%, and 72.4% of participants achieving >80% completion rate. Median completion time was 1.80 min. During the 90‐day study period, 215 predefined alerts were generated, of which 101 (47.0%) prompted clinical intervention within 48 h, frequently occurring outside routine clinic visits. SMS‐based remote monitoring demonstrated high feasibility, sustained engagement and minimal patient burden. This platform enabled real‐time identification of symptoms and facilitated rapid follow‐up by clinicians, supporting its potential for remote therapeutic monitoring rather than a passive data collection tool.
- 16 November 2026
- Published by Wiley in British Journal of Haematology
Open AccessA real‐time text‐based assessment tool for monitoring symptoms and quality of life for multiple myeloma patients: A feasibility study
Summary: Patient‐reported outcome (PRO) and quality of life (QoL) assessments for multiple myeloma (MM) patients are traditionally collected at infrequent intervals using burdensome instruments, resulting in limited clinical visibility between visits. This creates a critical gap in care, as evolving symptoms and treatment‐related toxicities frequently occur outside scheduled encounters and may remain unrecognized. A single‐centre pilot study evaluated the feasibility and clinical utility of a short message service (SMS)‐based remote monitoring platform, assessing 8 symptoms and 10 QoL domains for 58 MM patients over 90 days. End‐points included feasibility and engagement measured using completion rates, time burden and identification of clinically actionable events. A total of 1604 assessments were delivered, with an overall completion rate of 85.5%, and 72.4% of participants achieving >80% completion rate. Median completion time was 1.80 min. During the 90‐day study period, 215 predefined alerts were generated, of which 101 (47.0%) prompted clinical intervention within 48 h, frequently occurring outside routine clinic visits. SMS‐based remote monitoring demonstrated high feasibility, sustained engagement and minimal patient burden. This platform enabled real‐time identification of symptoms and facilitated rapid follow‐up by clinicians, supporting its potential for remote therapeutic monitoring rather than a passive data collection tool.